News ( Year: 2015 )

SORT BY YEAR
10 December, 2015

WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private Transaction

SHANGHAI, Dec. 10, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced the completion of its merger (the “Merger”) with WuXi Merger Limited (“Merger Sub”), a wholly-owned subsidiary […]

Read More
14 August, 2015

Wuxi Pharmatech Enters Into Definitive Merger Agreement

SHANGHAI, Aug. 14, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company”) (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced that it has entered into a definitive Agreement and Plan of Merger (the “Merger […]

Read More
30 April, 2015

WuXi PharmaTech Announces Receipt of Proposal

SHANGHAI, April 30, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company“) (NYSE: WX), a leading global contract R&D services provider, today announced that its board of directors has received a preliminary non-binding proposal letter, dated April 29, 2015, from a consortium (the “Consortium“) led by Dr. Ge Li (the “Chairman“), founder, chairman and chief executive officer of the […]

Read More